Patent Assignment
Reel/Frame 067221/0958
Release of Security Interest
Recorded: 2024-04-25
Pages: 12
Assignor
WILMINGTON TRUST, NATIONAL ASSOCIATION
Executed: 2024-04-23
Assignees
ENDO GLOBAL AESTHETICS LIMITED
FIRST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD, BALLSBRIDGE, 4, IRELAND
ENDO GLOBAL VENTURES
VICTORIA PLACE, 5TH FLOOR, 31 VICTORIA STREET, HAMILTON, HM 10, BERMUDA
ENDO VENTURES BERMUDA LIMITED
VICTORIA PLACE, 5TH FLOOR, 31 VICTORIA STREET, HAMILTON, HM 10, BERMUDA
ENDO VENTURES LIMITED
FIRST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD, BALLSBRIDGE, 4, IRELAND
PALADIN LABS INC.
100 ALEXIS-NIHON BLVD, SUITE 600, ST-LAURENT, H4M 2P2, CANADA
Covered Properties
(33)
Polymeric micelle compositions
Patent:
6,338,859 →
Application:
09/606,398 →
Cross-Linked High Amylose Starch for Use in Controlled-Release Pharmaceutical Formulations and Processes for Its Manufacture
Patent:
6,607,748 →
Application:
09/606,399 →
Water-Soluble Stabilized Self-Assembled Polyelectrolytes
Unimolecular Polymeric Micelles with an Ionizable Inner Core
Amphiphilic Diblock, Triblock and Star-Block Copolymers and Their Pharmaceutical Compositions
Preparation of Sterile Stabilized Nanodispersions
13C Glucose Breath Test for the Diagnosis of Diabetic Indications and Monitoring Glycemic Control
Ph-Sensitive Block Copolymers for Pharmaceutical Compositions
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Controlled-release compositions
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Compositions and Methods for Treating Collagen-Mediated Diseases
Process for the Preparation of Amphiphilic Poly(N-Vinyl-2-Pyrrolidone) Block Copolymers
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Narcotic Drug Formulations with Decreased Abuse Potential
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Method of Treating or Reducing EFP
Application:
14/255,407 →
Publication:
US 2014/0335072
Misuse Preventative, Controlled Release Formulation
Misuse Preventative, Controlled Release Formulation
Clostridium Histolyticum Enzymes and Methods for the Use Thereof
Oligonucleotide Duplexes Comprising Dna-Like and Rna-Like Nucleotides and Uses Thereof
Compositions and Methods for Treating Collagen-Mediated Diseases
Application:
15/160,392 →
Publication:
US 2017/0087229
Clostridium Histolyticum Enzymes and Methods for the Use Thereof
Starch-Based Microparticles for the Release of Agents Disposed Therein
Application:
15/782,557 →
Publication:
US 2018/0193466
Solid Formulations of Liquid Biologically Active Agents
Method of Assessing and Treating Cellulite
Method of Producing Collagenase
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Jan 29, 2015
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: AUXILIUM PHARMACEUTICALS, INC.; TIMM MEDICAL TECHNOLOGIES, INC.; ACTIENT PHARMACEUTICALS LLC; SLATE PHARMACEUTICALS, INC.
Reel/Frame 034843/0096 →
Security Interest
Feb 4, 2015
From: AUXILIUM US HOLDINGS, LLC; AUXILIUM INTERNATIONAL HOLDINGS, INC.; ACTIENT HOLDINGS LLC; ACTIENT PHARMACEUTICALS LLC
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 034890/0315 →
Assignment of Assignor's Interest
Mar 2, 2015
From: AUXILIUM US HOLDINGS, LLC
To: AUXILIUM BERMUDA UNLIMITED
Reel/Frame 035113/0663 →
Change of Name
Jul 13, 2016
From: AUXILIUM BERMUDA UNLIMITED
To: ENDO GLOBAL VENTURES
Reel/Frame 039336/0729 →
Assignment of Assignor's Interest
Jul 19, 2016
From: BIOSPECIFICS TECHNOLOGIES CORP.
To: BIOSPECIFICS TECHNOLOGIES CORP.; AUXILIUM US HOLDINGS, LLC
Reel/Frame 039191/0001 →
Release of Security Interest
Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AUXILIUM US HOLDINGS, LLC; AUXILIUM INTERNATIONAL HOLDINGS, LLC; ACTIENT PHARMACEUTICALS LLC; SLATE PHARMACEUTICALS, LLC
Reel/Frame 042172/0421 →
Confirmatory Grant of Security Interest in United States Patents
May 26, 2020
From: ENDO GLOBAL VENTURES; ENDO VENTURES LIMITED; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 053548/0239 →
Assignment of Assignor's Interest
Jul 27, 2020
From: ENDO GLOBAL VENTURES
To: ENDO GLOBAL AESTHETICS LIMITED
Reel/Frame 053321/0654 →
Assignment of Assignor's Interest
Jul 27, 2020
From: YU, BO; WEGMAN, THOMAS L.
To: BIOSPECIFICS TECHNOLOGIES CORP.
Reel/Frame 053321/0701 →
Assignment of Assignor's Interest
May 6, 2021
From: ISOTECHNIKA INC.
To: PALADIN LABS INC.
Reel/Frame 056160/0399 →
Change of Name
Jun 30, 2021
From: BIOSPECIFICS TECHNOLOGIES CORP.
To: BIOSPECIFICS TECHNOLOGIES LLC
Reel/Frame 056774/0545 →
Confirmatory Grant of Security Interest in United States Patents
Sep 17, 2021
From: ENDO VENTURES LIMITED; ENDO GLOBAL VENTURES; PALADIN LABS INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 057538/0893 →
Change of Name
Mar 5, 2024
From: OPERAND PHARMACEUTICALS III LIMITED
To: ENDO OPERATIONS LIMITED
Reel/Frame 066732/0413 →
Assignment of Assignor's Interest
Mar 5, 2024
From: ENDO VENTURES UNLIMITED COMPANY
To: OPERAND PHARMACEUTICALS III LIMITED
Reel/Frame 066732/0137 →
Change of Name
Mar 5, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 066732/0396 →
Assignment of Assignor's Interest
Apr 23, 2024
From: BIOSPECIFICS TECHNOLOGIES LLC
To: ENDO USA, INC.
Reel/Frame 067198/0623 →
Assignment of Assignor's Interest
Apr 23, 2024
From: PALADIN LABS INC.
To: PALADIN PHARMA INC.
Reel/Frame 067203/0281 →
Assignment of Assignor's Interest
Apr 23, 2024
From: ENDO GLOBAL AESTHETICS LIMITED
To: PALADIN PHARMA INC.
Reel/Frame 067198/0598 →
Release of Security Interest
Apr 24, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ENDO GLOBAL AESTHETICS LIMITED; ENDO GLOBAL VENTURES; ENDO VENTURES BERMUDA LIMITED; ENDO VENTURES LIMITED
Reel/Frame 067216/0376 →
Assignment of Assignor's Interest
Apr 27, 2024
From: ENDO USA, INC.
To: ENDO BIOLOGICS LIMITED
Reel/Frame 067245/0693 →
Assignment of Assignor's Interest
Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO BIOLOGICS LIMITED
Reel/Frame 067245/0736 →
Assignment of Assignor's Interest
Apr 27, 2024
From: PALADIN PHARMA INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0714 →
Change of Name
Jun 20, 2024
From: ENDO VENTURES LIMITED
To: ENDO VENTURES UNLIMITED COMPANY
Reel/Frame 067994/0211 →
Assignment of Assignor's Interest
Jun 20, 2024
From: PALADIN LABS (BARBADOS) INC.
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067778/0988 →
Assignment of Assignor's Interest
Jun 20, 2024
From: PALADIN LABS EUROPE LIMITED
To: ENDO VENTURES UNLIMITED COMPANY (F/K/A ENDO VENTURES LIMITED)
Reel/Frame 067779/0054 →